The resulting s-ALCAM levels in our patients (mean 28.9 ng/ml) are below those reported for breast cancer patients (74 ng/ml; [15]) and ovarian cancer patients (mean 44 ng/ml; [14]), but slightly above those found in patients with esophageal carcinoma (mean 23.9 ng/ml; [26]). Here, ALCAM is linked to breast cancer.